Results 201 to 210 of about 318,970 (339)

Consensus on the Management of Anesthetic Agents During Digestive Motility Measurements and Proposal of a Standardized Protocol for Anesthesia (French Neuro Gastroenterology Group GFNG and Committee of Anesthetic French Experts)

open access: yesNeurogastroenterology &Motility, EarlyView.
Anesthesia can alter measurements during digestive endoscopies, yet no standardized protocol currently exists. Two expert groups—the French Neuro‐Gastroenterology Group (GFNG) and anesthesiologists—used the Delphi method to reach a consensus on which drugs have an influence (91 amendments), ultimately resulting in a proposed anesthesia protocol (28 ...
Domitille Renard   +29 more
wiley   +1 more source

Optimizing the Straight Leg Raise Maneuver to Improve Prediction of Conclusive Gastro‐Esophageal Reflux Disease

open access: yesNeurogastroenterology &Motility, EarlyView.
The SLR maneuver is a valuable component of GERD evaluation. By establishing optimal thresholds for both effective EGJ challenge and accurate GERD prediction, we provide another step for standardized implementation in clinical practice. ABSTRACT Background Gastroesophageal reflux disease (GERD) arises from dysfunction of the anti‐reflux barrier.
Stefano Siboni   +7 more
wiley   +1 more source

Human intestinal and multivisceral transplantation [PDF]

open access: yes, 1994
Abu-Elmagd, K   +8 more
core  

Evidence for Brain‐To‐Gut and Gut‐To‐Brain Pathways in Primary Care Patients With Disorders of Gut‐Brain Interaction, Inflammatory Bowel Disease and Gastroesophageal Reflux Disease

open access: yesNeurogastroenterology &Motility, EarlyView.
Gut–brain pathways are bidirectional, but one pathway may predominate in certain disorders. The brain‐to‐gut pathway predominates in IBS, FD, and GERD, while a gut‐to‐brain disturbance dominates in overlap IBS/FD. Prior medications and gastroenteritis may indicate gut‐brain disturbances and may lead first to DGBI or GERD and later psychological ...
N. A. Koloski   +4 more
wiley   +1 more source

Efficacy and Safety of the Enterosorbent Silicolgel in Irritable Bowel Syndrome, IBS‐D and IBS‐M: A Randomized, Double‐Blind, Placebo‐Controlled, Multi‐Center Trial

open access: yesNeurogastroenterology &Motility, EarlyView.
Current treatments often fall short in managing IBS effectively. Silicolgel, an enterosorbent, reduced IBS and other gastrointestinal symptoms in 90% of IBS patients compared to 20% in those on placebo. Enterosorbents are not currently recommended for IBS; silicolgel is a widely available, affordable option for patients with IBS‐D and IBS‐M.
O. Kuzminska   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy